International Stem Cell Corp. (OTCMKTS:ISCO) Shares Shorted: Short Interest Down 94.1% in September

International Stem Cell Corp. (OTCMKTS:ISCO) was the target of a significant drop in short interest in the month of September. As of September 15th, there was short interest totaling 48 shares, a drop of 94.1% from the August 31st total of 808 shares. Based on an average trading volume of 124,095 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

International Stem Cell Price Performance

International Stem Cell stock opened at $0.35 on Friday. The firm has a market cap of $2.76 million and a PE ratio of -4.32. The stock’s fifty day moving average price is $0.35 and its two-hundred day moving average price is $0.23. International Stem Cell has a one year low of $0.12 and a one year high of $0.54.

International Stem Cell (OTCMKTS:ISCO) last released its earnings results on Thursday, August 13th. The biotechnology company reported ($0.01) earnings per share for the quarter. The business had revenue of $2.67 million during the quarter.

About International Stem Cell

International Stem Cell Corporation is a biotechnology company focused on developing human stem cell-based products and therapies. Its research has centered on proprietary parthenogenetic human stem cells, which are derived from unfertilized human oocytes and are intended to provide a potentially useful source of cells for regenerative medicine.

The company has pursued applications in tissue engineering and cell therapy, including programs involving corneal tissue and other specialized cell types.